Coordination of membrane traffic on the exocytic pathway through rab GEF and rab
通过 rab GEF 和 rab 胞吐途径上的膜运输的协调
基本信息
- 批准号:8089249
- 负责人:
- 金额:$ 28.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigen PresentationBindingBinding ProteinsCell PolarityCell Surface ReceptorsCell physiologyCellsCollectionComplexCoupledDiabetes MellitusDrosophila genusEpithelial CellsGTP BindingGTPase-Activating ProteinsGlucose TransporterGolgi ApparatusGuanine Nucleotide Exchange FactorsGuanosine TriphosphateHomologous GeneIn VitroInsulinLabelLarvaLinkLipid BindingMaintenanceMalignant NeoplasmsMembraneMembrane Protein TrafficMolecularMolecular ConformationNerve DegenerationPathway interactionsPhosphatidylinositolsPhosphotransferasesPhysiologicalProductionProtein BindingProteinsReactionRecruitment ActivityRegulationRoleSNAP receptorSecretory ComponentSecretory VesiclesSorting - Cell MovementStagingStructureSystemTestingTimeTumor Suppressor ProteinsVesiclehuman diseasein vivoneurotransmissionrab GTP-Binding Proteinsresponse
项目摘要
DESCRIPTION (provided by applicant): Membrane traffic is required for a broad range of essential cellular functions, such as controlling the accessibility of cell surface receptors, the translocation of glucose transporters in response to insulin, antigen presentation, neuronal transmission and the establishment and maintenance of epithelial cell polarity. Therefore, the regulation of membrane traffic is directly relevant to a broad range of human diseases including cancer, diabetes and neural degeneration. Rab GTPases are key regulators of membrane traffic. By recruiting and activating a functionally diverse set of effectors, a single Rab GTPase can coordinate the various sub- reactions within a given stage of membrane traffic, including vesicle budding, delivery, tethering and fusion. Furthermore, our results indicate that adjacent stages of transport can also be coupled through coordinated rab regulation. We recently defined a rab guanine nucleotide exchange factor (GEF) cascade in which one rab, in its GTP-bound state, recruits the GEF that activates the next rab along the exocytic pathway. We also have preliminary evidence for a rab GTPase activating protein (GAP) cascade operating in a counter current fashion. Here the downstream rab recruits the GAP that inactivates the upstream rab. The net effect is rab conversion in which a given patch of membrane starts out labeled with one rab, but over time becomes labeled with another rab. Since each rab recruits and activates a distinct set of effectors, this leads to a functional maturation of the membrane. We will explore these two cascade mechanisms in further detail and test the physiological consequences of uncoupling adjacent stages of membrane traffic. We will test the role of a Sec4p effector in SNARE assembly and explore the roles of several new putative Sec4p effectors. Through these studies we will begin to define the exocytic pathway as a fully coordinated system, rather than as a collection of isolated sub-reactions. Membrane traffic is the mechanism by which material is transferred between different compartments within the cell and the regulation of membrane traffic is directly relevant to a broad range of human diseases including cancer, diabetes and neural degeneration. This study addresses the molecular mechanisms by which different stages of membrane traffic are coordinately regulated.
描述(申请人提供):膜交通是一系列基本的细胞功能所必需的,例如控制细胞表面受体的可及性、葡萄糖转运体对胰岛素的反应、抗原递呈、神经元传递以及上皮细胞极性的建立和维持。因此,膜交通的调节与包括癌症、糖尿病和神经变性在内的广泛的人类疾病直接相关。Rab GTP酶是膜交通的关键调节因子。通过招募和激活一组功能不同的效应器,单个Rab GTP酶可以协调给定的膜运输阶段的各种亚反应,包括囊泡萌发、传递、系留和融合。此外,我们的结果表明,相邻的运输阶段也可以通过协调的RAB调节来耦合。我们最近定义了一个Rab鸟嘌呤核苷酸交换因子级联,在这个级联中,一个Rab处于GTP结合的状态,招募沿着胞外途径激活下一个Rab的Gab。我们也有初步证据表明Rab GTPase激活蛋白(GAP)级联以逆流方式运行。在这里,下游的RAB招募了使上游RAB失活的缺口。净效应是Rab转换,其中给定的膜片开始标记一个Rab,但随着时间的推移,变得标记另一个Rab。由于每个RAB招募并激活一组不同的效应器,这导致膜的功能成熟。我们将更详细地探索这两个级联机制,并测试分离相邻的膜交通阶段的生理后果。我们将测试Sec4P效应器在陷阱组装中的作用,并探索几个新的假定的Sec4P效应器的作用。通过这些研究,我们将开始将胞外途径定义为一个完全协调的系统,而不是一个孤立的子反应的集合。膜运输是物质在细胞内不同隔室之间转移的机制,膜运输的调节与包括癌症、糖尿病和神经变性在内的一系列人类疾病直接相关。这项研究探讨了膜运输的不同阶段被协调调节的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER Jay NOVICK其他文献
PETER Jay NOVICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER Jay NOVICK', 18)}}的其他基金
Coordination of membrane traffic through rab GEF and GAP cascades
通过 rab GEF 和 GAP 级联协调膜运输
- 批准号:
8508270 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic through rab GEF and GAP cascades
通过 rab GEF 和 GAP 级联协调膜运输
- 批准号:
9094212 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic through rab GEF and GAP cascades
通过 rab GEF 和 GAP 级联协调膜运输
- 批准号:
9381420 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic on the exocytic pathway through rab GEF and rab
通过 rab GEF 和 rab 胞吐途径上的膜运输的协调
- 批准号:
7349784 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic through rab GEF and GAP cascades
通过 rab GEF 和 GAP 级联协调膜运输
- 批准号:
8370432 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic through rab GEF and GAP cascades
通过 rab GEF 和 GAP 级联协调膜运输
- 批准号:
8873982 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic on the exocytic pathway through rab GEF and rab
通过 rab GEF 和 rab 胞吐途径上的膜运输的协调
- 批准号:
7645018 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic on the exocytic pathway through rab GEF and rab
通过 rab GEF 和 rab 胞吐途径上的膜运输的协调
- 批准号:
7885431 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
Coordination of membrane traffic through rab GEF and GAP cascades
通过 rab GEF 和 GAP 级联协调膜运输
- 批准号:
8692849 - 财政年份:2008
- 资助金额:
$ 28.77万 - 项目类别:
IDENTIFICATION OF PROTEINS THAT INTERACT WITH THE EXOCYST COMPLEX
与外囊复合物相互作用的蛋白质的鉴定
- 批准号:
7602219 - 财政年份:2007
- 资助金额:
$ 28.77万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 28.77万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 28.77万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 28.77万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 28.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 28.77万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 28.77万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 28.77万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 28.77万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 28.77万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 28.77万 - 项目类别: